About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Virtual Reality for Parent Training Intervention | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNANCT05809388

Virtual Reality for Parent Training Intervention

Previous research has shown how parental responses can affect ADHD symptoms by triggering dysfunctional cyclic processes. Therefore, it may be useful within rehabilitative treatments to include parent...

Lead sponsor: IRCCS Centro Neurolesi Bonino Pulejo•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Adriana Piccolo, Psy

CONTACT

09060128257 adriana.piccolo@irccsme.it

Sponsors

Lead Sponsor

IRCCS Centro Neurolesi Bonino Pulejo

The investigators designed a single-blind, randomized, controlled study on ADHD patients and their parents, with the aim of evaluating the effects of virtual reality support during PT program compared to traditional PT sessions.

Age

6 - 10 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patients diagnosed with ADHD, according to Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria;
•Age including 6 to 10 years;
•Subjects with IQ \>70;
•Signed informed consent and the availability of at least one family member to participate in the diagnostic/therapeutic process.

Exclusion Criteria

•Important comorbidities with psychiatric or neurological syndromes (e.g., epilepsy, known genetic syndromes, infantile cerebral palsy, sensory deficits);
•Subjects under the age of 6 years;
•Subjects older than 10 years of age;
•Subjects diagnosed with intellectual disability (IQ ≤70);
•Informed consent not signed and/or unavailability of at least one family member to participate in the diagnostic/therapeutic process.

Related studies

RECRUITINGPhase 2

Clinical Trial to Investigate the Safety and Efficacy of Two Dexamfetamine Sulfate Formulations in Adults With ADHD and Moderate to Severe Depression

NCT06967857 · Attention-Deficit/Hyperactivity Disorder (ADHD), Depression - Major Depressive Disorder

Not Yet RecruitingNA

The ADHD Kids´ Study for Children 9-12 Years of Age

NCT07379359 · Attention-Deficit/Hyperactivity Disorder (ADHD)

Reward Effects on Cognition, Motor Skills, and Motivation in Children

NCT06798337 · Attention-Deficit/Hyperactivity Disorder (ADHD)

COMPLETEDPhase 3

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD

NCT04016779 · Attention-Deficit/Hyperactivity Disorder (ADHD)

COMPLETEDPhase 2

Efficacy and Safety of SPN-812 (Viloxazine Extended-release Capsule) in Children With ADHD

NCT02633527 · Attention-Deficit/Hyperactivity Disorder (ADHD)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 24, 2023Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment68

Start dateOct 2022

Last updatedMay 24, 2023

Condition

Attention-Deficit/Hyperactivity Disorder (ADHD)

Locations shown

IRCCS Centro Neurolesi Bonino Pulejo

Messina

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 24, 2023Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions